A setback in growing light-responsive crystals led UB chemist Jason Benedict and his team to a novel method for mapping molecular arrangements.

Should the United States buy more destroyers, or would the money be better spent developing bases, munitions, or software?

Schema Compare shows the differences between two database structures. It highlights changes in a clean diff view and generates scripts to align one side with the other. See Schema Compare guide.

DBeaver lets you compare two database objects side by side and see how their structures differ. You can compare databases, schemas, or tables, then view the changes in a clean, lightweight report.

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...

A controlled test compared three nearly identical pages: one with strong schema, one with poor schema, and one with none. Only the page with well-implemented schema appeared in an AI Overview and ...

The Centers for Medicare & Medicaid Services announced Friday it is freezing its chief nursing home information source for consumers to ensure data accuracy after behind-the-scenes technical changes.

The reported cryo-EM imaging of a pentameric ligand-gated ion channel in liposomes as opposed to nanodiscs has both broad implications and contributes valuable methodological advances to the ...

This study aimed to: (i) compare the accumulated load between three and four training sessions per week plus a match across two consecutive seasons in elite female soccer players, and (ii) compare the ...